AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Spikalon DV 750mcg Tablet ER

Prescription Icon
Prescription Required

Marketer

KC Laboratories

Salt Composition

Divalproex (750mcg)

Overview Spikalon DV 750mcg Tablet ER

Epileptic seizures and migraine prophylaxis are key indications for the extended-release Spikalon DV 750mcg tablet. This medication also finds occasional use in managing bipolar disorder, often employed either independently or as part of a combination therapy. Dosage and frequency are determined individually by your physician to optimize symptom control. Administer the medication at the same time daily, with or without food, for consistent efficacy. Therapeutic effects generally manifest within a couple of weeks. Continuous use, as prescribed, is crucial; discontinuation or missed doses can precipitate seizures and exacerbate the underlying condition. Abrupt cessation should be avoided. Commonly reported side effects include headache, visual blurring, nausea, vomiting, dizziness, fatigue, imbalance, easy bruising, and hypothermia. While usually mild, persistent or troublesome effects warrant medical consultation. Immediate medical attention is required for any skin rash or redness. Prolonged use may contribute to osteoporosis and increased fracture risk. Suicidal ideation and behavior are rare but potential adverse effects, necessitating prompt medical intervention should mood deterioration occur. Prior to initiating treatment, inform your doctor of any pre-existing heart conditions, hepatic or renal impairment, urinary difficulties, depression, or history of suicidal thoughts. Numerous drug interactions are possible; therefore, comprehensive disclosure of all concurrent medications is essential for safe and effective use. Consult your physician before altering Spikalon DV 750mcg Tablet ER usage during pregnancy. Alcohol consumption should be minimized to mitigate potential side effects and seizure risk. Regular blood monitoring, both pre- and post-treatment initiation, assists in dose optimization.

Primary Ingredients of Spikalon DV 750mcg Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of Spikalon DV 750mcg Tablet ER

Managing epilepsy and seizures | Bipolar disorder therapy | Migraine prophylaxis

Major Benefits of Spikalon DV 750mcg Tablet ER:

Administer Spikalon DV 750mcg Extended-Release Tablets precisely as directed by your physician. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consumption with or without food is acceptable; however, consistent daily timing is recommended.

Common Side effects of Spikalon DV 750mcg Tablet ER:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Spikalon DV 750mcg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Spikalon DV 750mcg Extended-Release Tablet whole; do not chew, crush, or divide it. While this medication can be taken with or without food, consistent timing is recommended for optimal results.

How Spikalon DV 750mcg Tablet ER works:

Epileptic seizures are managed by Spikalon DV 750mcg Extended-Release tablets, an anticonvulsant drug that reduces heightened, irregular neuronal firing in the brain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Spikalon DV 750mcg extended-release tablets and alcohol can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Spikalon DV 750mcg tablets present a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional circumstances involving a life-threatening condition, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Spikalon DV 750mcg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Extended-release Spikalon DV 750mcg tablets may impair driving ability due to potential adverse effects.

KidneyKidneySAFE IF PRESCRIBED

Spikalon DV 750mcg extended-release tablets pose no safety concerns for patients with renal impairment; dosage modification is unnecessary.

LiverLiverUNSAFE

The use of Spikalon DV 750mcg Extended-Release Tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Spikalon DV 750mcg Tablet ER :

Should you forget to take a Spikalon DV 750mcg Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Spikalon DV 750mcg Tablet ER

LabelValue
Chemical Type Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience and the Central Nervous System
Actions Sodium channel-blocking antiepileptic drugs

FAQs on Spikalon DV 750mcg Tablet ER

Always consult your doctor before discontinuing Spikalon DV 750mcg Tablet ER. Withdrawal should be gradual, under medical supervision, to avoid potential symptoms like irritability, anxiety, dizziness, tremors, or a return of your original condition.
Spikalon DV 750mcg Tablet ER may be used to stabilize mood in patients experiencing rapid mood swings. Its mechanism involves reducing excessive brain activity associated with these mood changes.
Weight gain is a possible side effect of Spikalon DV 750mcg Tablet ER, potentially resulting from increased appetite. To minimize this, maintain a healthy diet and exercise regularly. Consult your doctor if weight gain is a concern.
Spikalon DV 750mcg Tablet ER may cause drowsiness. Refrain from driving or activities requiring alertness until you understand its effects on you.
Hair loss is a possible, temporary side effect of Spikalon DV 750mcg Tablet ER, often linked to dosage. Consult your doctor if this occurs or continues.
Spikalon DV 750mcg Tablet ER can cause liver damage, particularly within the first six months of treatment. Symptoms such as nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes) may indicate liver injury. Pre-treatment liver function tests are recommended, with regular monitoring during the initial six months, especially for at-risk individuals or those with a history of liver disease.
Refrain from drinking alcohol during your Spikalon DV 750mcg Tablet ER treatment. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Spikalon DV 750mcg Tablet ER treatment, your doctor may order blood tests. These may include a complete blood count (with platelet count), bleeding time, and coagulation tests to minimize the risk of bleeding or bruising. Liver function tests are also recommended before and, especially for high-risk individuals or those with a history of liver disease, during the first six months of treatment.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result necessitates immediate medication cessation.
Spikalon DV 750mcg Tablet ER overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Muscle weakness, seizures, unconsciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain may also occur. Seek immediate medical help if an overdose is suspected.
Spikalon DV 750mcg Tablet...
94
MRP 115
18% off